Business
TELA Bio’s OviTex® Reinforced Tissue Matrix to be Featured in Three Case Reports at SAGES 2023
Presentations highlight utility of this advanced hernia reinforcement material for robotic procedures MALVERN, Pa., March 29, 2023 (GLOBE NEWSWIRE) -- TELA
About this update from Tela Bio, Inc.
[{"type":"text","content":"Presentations highlight utility of this advanced hernia reinforcement material for robotic procedures\nMALVERN, Pa., March 29, 2023 (GLOBE NEWSWIRE) -- TELA Bio, Inc. (NASDAQ: TELA), a commercial-stage medical technology company focused on providing innovative soft-tissue reconstruction solutions that optimize clinical outcomes by prioritizing the preservation and restoration of the patient’s own anatomy, today announced its OviTex® Reinforced Tissue Matrix will be featured in three case reports at the Society of American Gastrointestinal and Endoscopic Surgeons (SAGES) conference from March 29 - April 1, 2023, in Montreal, Canada. These case reports will help inform surgeons on techniques related to the use of OviTex in robot-assisted hernia repair. OviTex Reinforced Tissue Matrix is uniquely positioned as a tissue-derived hernia reinforcement option that can be utilized successfully in robotic and laparoscopic hernia repairs. “We’re excited and appreciative to see the use of OviTex in robotic hernia repair highlighted at SAGES,” said Antony Koblish, CEO of TELA Bio. “The unique design and handling characteristics of OviTex facilitates its use in minimally invasive procedures and allows surgeons to provide their patients a proven reinforcement option that reduces dependency on permanent synthetic mesh.” Presentations include: 1. Robotic Bilateral Transversus Abdominis Component Separation and Diaphragmatic Hernia Repair in an Immunosuppressed Heart Transplant Patient (Steven M Elzein, MD; Mu’ath Adlouni, BS; Ahad Azzimuddin, BS, MBA; Rodolfo J Oviedo, MD, FACS, FSMBS. Houston Methodist Hospital) 2. Robotic Transabdominal Preperitoneal (TAPP) for the Treatment of Spigelian Hernias (Yoon Kyung Lee, MD; Daniel Tomey, MD; Roberto Secchi, MD; Alessandro Martinino, MD; Rodolfo Oviedo, MD, FACS, FASMBS, FICS. Houston Methodist Hospital; Universidad Anahuac Queretaro; Sapienza University of Rome) 3. Traumatic Ventral and Diaphragmatic Hernias: A Case Report (Robert D Larsen, MS; John Azar, MS; Joseph Lewis, MD. Florida State University, University of Florida) The TELA Bio team will be attending SAGES 2023, Booth #301. For the event’s full agenda, visit: https://www.sages2023.org/schedule-at-a-glance/ About TELA Bio, Inc.TELA Bio, Inc. (NASDAQ: TELA) is a commercial-stage medical technology company focused on providing innovative techno...